tradingkey.logo

Gelteq Ltd

GELS
View Detailed Chart

1.650USD

+0.030+1.85%
Market hours ETQuotes delayed by 15 min
15.92MMarket Cap
LossP/E TTM

Gelteq Ltd

1.650

+0.030+1.85%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.85%

5 Days

-13.61%

1 Month

-4.07%

6 Months

-25.00%

Year to Date

-28.88%

1 Year

0.00%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(1)
Indicators
Sell(3)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.036
Neutral
RSI(14)
41.371
Neutral
STOCH(KDJ)(9,3,3)
16.534
Sell
ATR(14)
0.136
High Vlolatility
CCI(14)
-198.387
Sell
Williams %R
92.144
Oversold
TRIX(12,20)
0.034
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
1.781
Sell
MA10
1.830
Sell
MA20
1.815
Sell
MA50
1.826
Sell
MA100
1.603
Buy
MA200
1.915
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Ticker SymbolGELS
CompanyGelteq Ltd
CEOMr. Nathan Jacob Givoni
Websitehttps://www.gelteq.com
KeyAI